StocksW › WSM

Williams-Sonoma, Inc. (WSM) — Earnings Call X-Ray

Our AI read all 38 of WSM's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q1 2025 · sign up to see
Previous Call Grade
C+
Q4 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
38
2016–2025
Avg Candor
6.9/9
evasion 2.8/9
High CandorSkeptic ReassuredCritic AmmunitionEarly Product, Fast GrowthRaising PricesMargins ExpandingDemand AcceleratingBacklog Growing

Call-by-call analysis

🔒 Q1 2025 earnings call 2025-05-22 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q1 2025 call grade is ready
The full 37-point AI read of WSM's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C+ Q4 2024 earnings call 2025-03-19 move ±9.7%

Management held guidance steady against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: raisingHeadcount: flatCapex: increasing 7 analysts · 10 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 4/9
Promotion 6/9
Stress 2/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B+ Q3 2024 earnings call 2024-11-20 move ±15.4%

Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: raisedDemand: mixedMargins: expandingPricing: stableCapex: flat 9 analysts · 14 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 4/9
Promotion 6/9
Stress 1/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B Q2 2024 earnings call 2024-08-22 move ±15.9%

Management gave no formal guidance against slowing demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: mixedDemand: slowingMargins: expandingPricing: stableHeadcount: flatCapex: flat 9 analysts · 16 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growthHidden segment
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 6/9
Promotion 4/9
Stress 2/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B+ Q1 2024 earnings call 2024-05-22 move ±10.7%

Management raised guidance against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: stableMargins: expandingPricing: stableHeadcount: flatCapex: flat 10 analysts · 20 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 4/9
Promotion 5/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q4 2023 earnings call 2024-03-13 move ±11.5%

Management held guidance steady against mixed demand signals and expanding margins. The delivery was rich in specifics.

Guidance: maintainedDemand: mixedMargins: expandingPricing: stableHeadcount: cuttingCapex: increasing 7 analysts · 13 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsedDirection beats results
Candor 6/9
Specificity 8/9
Evasion 4/9
Confidence 8/9
Uncertainty 5/9
Promotion 5/9
Stress 2/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
From the research question bank
1 more research questions answered NO

B+ Q3 2023 earnings call 2023-11-16 move ±12.3%

Management raised guidance against slowing demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: slowingMargins: expandingPricing: stableHeadcount: cuttingCapex: decreasing 8 analysts · 14 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 8/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 5/9
Promotion 4/9
Stress 2/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B+ Q2 2023 earnings call 2023-08-23 move ±11.3%

Management raised guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: slowingMargins: contractingBacklog: growingPricing: under pressureHeadcount: cuttingCapex: flat 11 analysts · 11 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 3/9
Promotion 4/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q1 2023 2023-05-23 C+ maintainedslowingcontracting 7/9 2/9
Q4 2022 2023-03-16 C+ maintainedslowingcontracting 7/9 3/9
Q3 2022 2022-11-17 C maintainedmixedcontracting 7/9 2/9
Q2 2022 2022-08-24 B maintainedacceleratingexpanding 7/9 2/9
Q1 2022 2022-05-25 C+ maintainedmixedexpanding 7/9 3/9
Q4 2021 2022-03-16 C+ maintainedstableexpanding 7/9 4/9
Q3 2021 2021-11-18 B+ raisedacceleratingexpanding 7/9 2/9
Q2 2021 2021-08-25 B+ raisedacceleratingexpanding 8/9 2/9
Q1 2021 2021-05-26 B+ raisedacceleratingexpanding 7/9 3/9
Q4 2020 2021-03-17 A maintainedacceleratingexpanding 8/9 2/9
Q3 2020 2020-11-19 C withdrawnacceleratingexpanding 7/9 3/9
Q2 2020 2020-08-26 D withdrawnacceleratingexpanding 7/9 4/9
Q1 2020 2020-05-28 D withdrawnacceleratingcontracting 7/9 4/9
Q4 2019 2020-03-18 D withdrawnmixedcontracting 7/9 4/9
Q3 2019 2019-11-21 B+ raisedacceleratingstable 7/9 2/9
Q2 2019 2019-08-28 B+ raisedacceleratingexpanding 7/9 2/9
Q1 2019 2019-05-30 B raisedacceleratingexpanding 7/9 3/9
Q4 2018 2019-03-20 B maintainedstablestable 7/9 2/9
Q3 2018 2018-11-15 B maintainedacceleratingmixed 7/9 2/9
Q2 2018 2018-08-22 B+ raisedacceleratingexpanding 7/9 2/9
Q1 2018 2018-05-23 B raisedacceleratingexpanding 6/9 3/9
Q4 2017 2018-03-14 C+ noneacceleratingcontracting 6/9 3/9
Q3 2017 2017-11-16 C+ raisedacceleratingcontracting 6/9 3/9
Q2 2017 2017-08-23 C maintainedacceleratingcontracting 6/9 4/9
Q1 2017 2017-05-24 C+ maintainedmixedcontracting 7/9 3/9
Q4 2016 2017-03-15 D maintainedmixedexpanding 6/9 4/9
Q3 2016 2016-11-17 D loweredmixedstable 7/9 3/9
Q2 2016 2016-08-25 F loweredslowingcontracting 6/9 4/9
Q1 2016 2016-05-25 C maintainedmixedstable 6/9 3/9
Q4 2015 2016-03-16 C maintainedmixedcontracting 7/9 3/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of WSM's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

C+ Q4 2022 earnings call 2023-03-16

1 more research questions answered NO

D Q3 2016 earnings call 2016-11-17

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AA · Alcoa CorporationAAALF · Aareal Bank AGAABKF · Aareal Bank AGAAGIY · AIA Group LimitedAAL · American Airlines Group AAPL · Apple Inc.

WSG   All “W” companies    WSO

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.